SynthesisFrontiers in immunology2026
Efficacy and safety of obinutuzumab in refractory membranous nephropathy: a single-arm meta-analysis.
Pengli Cong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
SynthesisFrontiers in immunology2026
Pengli Cong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.